大小兴安岭可培养细菌的资源多样性

细菌作为微生物中的重要组成部分, 在有机质的形成与分解、维持生态系统平衡、促进动植物发育等多方面都有着重要作用。2014-2017年, 我们采用常见培养基分离纯培养法及16S rRNA基因序列分析方法对大小兴安岭地区土壤可培养细菌的群落结构和多样性进行了调查研究。结果表明: 从大小兴安岭地区的17个自然保护区内不同生境的土壤中分离获得3,180个菌株, 隶属于24属120种。其中, 芽孢杆菌属(Bacillus)的种数和株数最多, 分别为38种和2,419株, 是大小兴安岭地区可培养细菌的绝对优势类群(占总株数的76.1%); 其次是短杆菌属(Brevibacterium)(13.0%)。大兴安岭地区的物种数、Simpson多样性指数和Shannon-Wiener指数高于小兴安岭地区。优势类群芽孢杆菌属的枯草芽孢杆菌(B. subtilis)、苏云金芽孢杆菌(B. thuringiensis)、巨大芽孢杆菌(B. megaterium)等有重要的生产及科学研究价值。     

地衣芽胞杆菌BL63516对抗生素诱导的 菌群紊乱小鼠肠黏膜屏障功能的影响

目的探索地衣芽胞杆菌BL63516对肠道菌群和肠黏膜屏障功能调节的效果和可能机制,为临床疾病的治疗提供新思路。方法采用健康清洁级雄性BALB/C小鼠30只构建动物模型,将小鼠分为3组(每组10只),分别为对照组(CON组)、头孢曲松钠灌胃组(CS组)和地衣芽胞杆菌BL63516治疗组(BL组),除CON组外其余两组小鼠给予300 mg/mL头孢曲松钠0.2 mL,2次/d灌服8 d,短期大量服用抗生素以建立肠道菌群紊乱模型。第9天起BL组小鼠给予地衣芽胞杆菌干预连续8 d。第17天摘眼球处死小鼠,取血、结肠、粪便样本。ELISA方法检测小鼠血清及肝脏组织中的细胞因子及LPS水平。PCR-变性梯度凝胶电泳方法及16S rRNA高通量测序测定小鼠肠道菌群结构。结果地衣芽胞杆菌干预后小鼠血清LPS水平较模型组显著降低,屏障功能改善。且地衣芽胞杆菌治疗后BL组小鼠肠道菌群丰富度和多样性显著升高,菌群结构有所改变。结论实验结果提示地衣芽胞杆菌BL63516可以有效改善抗生素所致的肠道菌群失调,对肠屏障功能有一定调节作用。     

凝结芽胞杆菌BC01对白羽肉鸡生产性能、免疫器官指数及肠道大肠埃希菌的影响

为研究在饲料中添加凝结芽胞杆菌BC01对白羽肉鸡生产性能、免疫器官指数及肠道大肠埃希菌的影响,将240只白羽肉鸡随机分为4组,试验组1、试验组2、试验组3在饲料中添加凝结芽胞杆菌BC01的终浓度分别为1×10~8、2×10~8、3×10~8 cfu/kg,对照组日粮中不添加任何微生态制剂,饲养6周。结果显示,日粮中添加凝结芽胞杆菌BC01可显著提高肉鸡平均日增重(P0.05),显著降低料重比(P0.05),降低死淘率(P0.05),胸腺指数、法氏囊指数均显著高于对照组(P0.05),降低肠道中的大肠埃希菌数量。结果表明,日粮中添加凝结芽胞杆菌BC01,对肉鸡的生长性能有一定的促进作用,提高饲料转化率,提升肉鸡的免疫力,提高肉鸡饲养的经济价值。凝结芽胞杆菌BC01的最佳添加浓度为每公斤饲料添加2×10~8 cfu/kg。     

Biotransformation of eugenol to vanillin by a novel strain Bacillus safensis SMS1003

Due to the extensive applications of vanillin as flavored compound and increasing consumers concern for its natural and environment friendly mode of production, present work was focused on the selection of bacterial isolate capable of producing vanillin using eugenol biotransformation. Bacterial strain SMS1003 is evidenced as the potential strain for vanillin production and identified as Bacillus safensis (GeneBank accession no. MG561863) using biochemical tests and molecular phylogenic analysis of its 16S rDNA gene sequence. Molar yield of vanillin reached up to 10.7% (0.055?g/L) at 96?h of biotransformation using growing culture of B. safensis SMS1003 in following culture conditions: eugenol concentration 500?mg/L; temperature 37?°C; initial pH 7.0; inoculum volume 4%; volume of culture media 10%; and shaking speed 180?rpm. Vanillin was detected as the single metabolite with a molar yield of 26% (0.12?g/L) at 96?h using resting cells of B. safensis SMS1003. Product confirmation was based on spectral scan using photodiode array detector, Fourier-transform infrared spectroscopy, high-performance liquid chromatography, and mass spectroscopy.     

芽孢杆菌dhs-330-021菌粉的制备及稳定性研究

目的:利用喷雾干燥工艺制备芽孢杆菌dhs-330-021菌粉,并研究菌粉的活性及稳定性。方法:以脱脂乳、海藻糖、β-环糊精和谷氨酸钠为保护剂,采用喷雾干燥(条件为:进口温度100℃,出口温度50～60℃,进样速度2～4mL/min)制备芽孢杆菌菌粉,以喷干存活率和菌粉活菌数为指标,选择最佳制备条件。结果:获得喷干保护剂配方为脱脂乳10.0%、海藻糖6.0%、β-环糊精13.0%、谷氨酸钠15.0%,喷干存活率为65.9%,菌粉活菌数为1.38×109CFU/g,存放180 d后菌粉活菌数为1.03×10~9CFU/g。结论:喷雾干燥工艺可以用于芽孢杆菌dhs-330-021菌粉的制备,获得的菌粉稳定性较好。     

Production of recombinant beta-amylase of Bacillus aryabhattai

In this study, the effects of carbon source, nitrogen source, and metal ions on cell growth and Bacillus aryabhattai β-amylase production in recombinant Brevibacillus choshinensis were investigated. The optimal medium for β-amylase production, containing glucose (7.5?g·L^?1), pig bone peptone (40.0?g·L^?1), Mg²⁺ (0.05?mol·L^?1), and trace metal elements, was determined through single-factor experiments in shake flasks. When cultured in the optimized medium, the β-amylase yield reached 925.4?U mL^?1, which was 7.2-fold higher than that obtained in the initial medium. Besides, a modified feeding strategy was proposed and applied in a 3-L fermentor fed with glucose, which achieved a dry cell weight of 15.4?g L^?1. Through this cultivation approached 30?°C with 0?g·L^?1 initial glucose concentration, the maximum β-amylase activity reached 5371.8?U mL^?1, which was 41.7-fold higher than that obtained with the initial medium in shake flask.     

Biosurfactant production: emerging trends and promising strategies

Biosurfactants are economically most sought after biotechnological compounds of the 21st century. However, inefficient bioprocessing has mitigated the economical commercial production of these compounds. Although much work is being done on the use of low-cost substrates for their production, a paucity of literature exists on the upcoming bioprocess optimization strategies and their successes and potential for economical biosurfactant production. This review discusses some of the latest developments and most promising strategies to enhance and economize the biosurfactant production process. Recent market analysis, developments in the field of optimally formulated cost credit substrates for enhanced product formation and subsequent process economization are few of the critical aspects highlighted here. Use of nanoparticles and coproduction of biosurfactant along with other commercially important compounds like enzymes, are other upcoming bioprocess intensification strategies. The recent developments discussed here would not only give an overview of pertinent parameters for economic biosurfactant production but would also bring to fore multiple strategies that would open up new avenues of research on biosurfactant production. This would go a long way in making biosurfactants a commercially successful compound of the current century.